NCT06632574View on ClinicalTrials.gov

A Clinical Study of Paclitaxel Cationic Liposomes for the Treatment of Patients With Advanced Solid Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 19, 2014

Primary Completion Date

October 31, 2025

Study Completion Date

March 31, 2027

Conditions
Advanced Solid Tumor
Interventions
DRUG

paclitaxel cationic liposomes

Paclitaxel cationic liposomes is a modified new drug. In this study, administration is performed through arterial catheter infusion.

Trial Locations (1)

Unknown

RECRUITING

Zhongda Hospital, Southeast University, Nanjing

All Listed Sponsors
lead

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

INDUSTRY